Synaptic Vesicular Alterations after Traumatic Brain Injury
脑外伤后突触小泡的改变
基本信息
- 批准号:10683248
- 负责人:
- 金额:$ 42.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-15 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAcuteAttentionAttenuatedBiological AssayBlast InjuriesBrainBrain InjuriesCell membraneChronicClathrinClathrin Heavy ChainsClathrin Light ChainsCognitionCognitiveComputer ModelsDataDevelopmentDisease PathwayDockingEmotionalEndocytosisEventFemaleFluorescenceFunctional disorderGenesGlutamatesHippocampusHomeostasisImpaired cognitionImpairmentIndividualInjuryKnowledgeLaboratoriesLearningLightMapsMeasuresMediatingMembraneMemoryMemory impairmentMicroscopyModelingMolecularNeuronsNeurotransmittersPathologyPathway interactionsPatientsPharmacologyPlayPotassiumProteinsQuality of lifeRattusRecoveryRecovery of FunctionRecyclingReportingRoleSeveritiesSortingStructureSynapsesSynaptic VesiclesSynaptosomesSystemTechniquesTestingTherapeuticTherapeutic InterventionTraumatic Brain InjuryVesicleViralViral VectorWorkcognitive functioncontrolled cortical impactdensitygene networkgenetic signatureimmunoreactivityimprovedinnovationliquid chromatography mass spectrometrymaleneurobehavioralneurotransmissionneurotransmitter releasenew therapeutic targetnovelpreclinical studyrecruitrestorationsexsingle-cell RNA sequencingspatial memorysynaptic functiontargeted treatmenttherapeutic target
项目摘要
Abstract
Enduring cognitive, somatic, and emotional impairments, including difficulties with memory, attention, and
learning, are reported as major contributors to reduced quality of life from patients living with a traumatic brain
injury (TBI). Previous preclinical studies highlight the contribution of altered neurotransmission and synaptic
dysfunction in the development of cognitive impairments after a TBI. We recently identified a novel synaptic
pathology in which the density and distribution of the intrasynaptic vesicular pool is drastically reduced after an
experimental TBI, with direct implications for impaired neurotransmission and cognition. A similar finding of
altered vesicle docking was observed after low intensity blast injury, suggesting these alterations may occur
across a broad spectrum of injury severity. Under normal conditions, neurotransmitter-containing vesicles are
replenished and the vesicular pool is maintained through the primary recycling mechanism of clathrin-mediated
endocytosis (CME). In the synapse, clathrin light chain (CLC) plays a central role in vesicular recycling through
interaction with clathrin heavy chain and CME associated proteins for vesicle formation and replenishment of the
vesicular pool. The effect of TBI on CLC and the contribution of CME deficits in synaptic dysfunction have not
been examined. We provide preliminary data highlighting reductions in CLC and CME proteins for weeks post-
injury in a rat model of controlled cortical impact (CCI). We also provide novel evidence of impaired hippocampal
evoked neurotransmitter release, a functional readout of vesicular pool integrity and CME function. We
hypothesize TBI-induced reductions in CME impairs the vesicular pool and neurotransmitter release, and that a
targeted strategy to promote endocytosis improves neurotransmission and cognitive function after TBI. We
propose utilizing innovative approaches to mechanistically interrogate the role of CLC and CME in post-traumatic
synaptic dysfunction and investigate the functional effects of targeted therapeutic intervention on CLC
abundance and CME function. In Aim 1, the effect of TBI on regional and sex-dependent changes in CLC and
CME will be assessed in the early to subchronic recovery period following CCI. In Aim 2, we will examine the
effect of a targeted strategy to increase CLC expression using neuron-specific adeno-associated viral modulation
on CME function on protein readouts, evoked neurotransmission and cognitive function following CCI. Aim 3 will
utilize an innovative and integrative Quantitative Systems Pharmacology approach to computationally model
gene changes in network map pathways altered after TBI and to identify perturbed pathways responsive to AAV-
CLC modulation after TBI. Successful completion of this work will bridge an important knowledge gap in
understanding the detrimental effects of TBI on the synapse and identify CLC and CME function as a novel
therapeutic target to promote functional recovery after a TBI.
摘要
持久的认知、躯体和情绪障碍,包括记忆、注意力和精神障碍
据报道,学习是导致脑外伤患者生活质量下降的主要原因
损伤(TBI)。先前的临床前研究强调了神经传递和突触改变的作用
脑外伤后认知功能障碍的发展。我们最近发现了一种新的突触
突触内水泡池的密度和分布在急性脑损伤后急剧减少的一种病理
实验性脑外伤,与神经传递和认知受损有直接关系。一项类似的发现
在低强度冲击伤后观察到改变的囊泡停靠,提示这些改变可能发生。
伤情严重程度各不相同。在正常情况下,含有神经递质的囊泡
通过网状蛋白介导的初级循环机制来补充和维持囊泡池
内吞作用(CME)。在突触中,网状蛋白轻链(clathrin light chain,CLC)通过
与胞蛋白重链和CME相关蛋白相互作用对囊泡形成和补充的影响
水泡泳池。颅脑损伤对CLC的影响以及CME缺陷在突触功能障碍中的作用
被检查过了。我们提供了初步数据,强调了CLC和CME蛋白在术后几周的减少。
控制皮质撞击(CCI)大鼠模型中的损伤。我们还提供了海马区受损的新证据。
诱发的神经递质释放,囊泡池完整性和CME功能的功能读数。我们
假设脑损伤诱导的CME减少会损害囊泡池和神经递质的释放,并且
促进内吞作用的靶向策略可改善脑外伤后的神经传递和认知功能。我们
建议利用创新的方法机械地审问《中图法》和《继续医学教育》在创伤后的作用
突触功能障碍与靶向治疗对慢性淋巴细胞性肺癌功能的影响
丰度与CME功能。在目标1中,脑创伤对CLC和CLC的区域性和性别依赖性变化的影响
CME将在CCI后早期到亚慢性恢复期进行评估。在目标2中,我们将研究
利用神经元特异腺相关病毒调节增加ClC表达的靶向策略的作用
持续脑电对CCI后蛋白质读数、诱发神经传递和认知功能的影响。目标3将
利用创新和综合的定量系统药理学方法建立计算模型
颅脑损伤后网络图通路的基因变化及识别对甲型肝炎病毒反应的扰动通路
脑损伤后的CLC调制。这项工作的成功完成将弥合以下方面的重要知识鸿沟
了解颅脑损伤对突触的不利影响并确定CLC和CME是一种新的功能
促进脑外伤后功能恢复的治疗目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHAUN CARLSON其他文献
SHAUN CARLSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHAUN CARLSON', 18)}}的其他基金
SV2A as a Therapeutic Target for Improved Neurotransmission after Traumatic Brain Injury
SV2A 作为改善脑外伤后神经传递的治疗靶点
- 批准号:
9893546 - 财政年份:2019
- 资助金额:
$ 42.48万 - 项目类别:
SV2A as a Therapeutic Target for Improved Neurotransmission after Traumatic Brain Injury
SV2A 作为改善脑外伤后神经传递的治疗靶点
- 批准号:
10017359 - 财政年份:2019
- 资助金额:
$ 42.48万 - 项目类别:
Lithium as a Therapeutic Approach to Attenuate Synaptic Deficits after TBI
锂作为减轻 TBI 后突触缺陷的治疗方法
- 批准号:
9177697 - 财政年份:2015
- 资助金额:
$ 42.48万 - 项目类别:
Lithium as a Therapeutic Approach to Attenuate Synaptic Deficits after TBI
锂作为减轻 TBI 后突触缺陷的治疗方法
- 批准号:
8977261 - 财政年份:2015
- 资助金额:
$ 42.48万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 42.48万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 42.48万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 42.48万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 42.48万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 42.48万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 42.48万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 42.48万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 42.48万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 42.48万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 42.48万 - 项目类别:
Operating Grants














{{item.name}}会员




